Detail akcie CryoLife online

Business Summary: Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Artivion Inc revenues increased 14% to $441.3M. Net income applicable to common stockholders totaled $9.8M vs. loss of $13.3M. Revenues reflect Medical devices segment increase of 19% to $345.8M, International segment increase of 14% to $227.3M, United States segment increase of 13% to $214.1M. Net Income reflects Other (income) expense, net - Balancing increase from $15.3M (expense) to $18K (income).